Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Group Walters currently holds 17,844,973 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Group Walters has been a net buyer of ZNTL stock. They have purchased $15.2M and sold $0 worth of shares.
Group Walters's most recent insider trade was on Aug 14, 2026, when they purchased 4,335,000 shares at $3.50 per share.
Group Walters serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 1 insider transactions totaling $15.2M over their tenure at the company.
Group Walters holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Group Walters has shown a buying trading pattern, with $15.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Group Walters was on Aug 14, 2026, when they purchased $15.2M worth of ZNTL shares. This transaction involved 4,335,000 shares at $3.50 per share.
Group Walters currently owns 17,844,973 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Group Walters's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Group Walters has 1 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for Group Walters and 40,000+ other insiders.